FDA Will Pursue Longer Follow-Up For Pediatric Studies, Murphy Says
Executive Summary
FDA plans to require longer follow-up for pediatric studies, CDER Associate Director of Pediatrics Dianne Murphy, MD, told the FDA Anti-Infective Drugs Advisory Committee/Pediatric Subcommittee April 23.